Healthcare & Life Sciences
FineHeart
FineHeart is a Healthcare & Life Sciences startup based in France, most recent round Series C+, 4 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2015
Founded
4
Investors
About FineHeart
FineHeart is a startup founded in 2015 based in France. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
FineHeart is a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology. Its main product, FlowMaker®, is an implantable cardiac assist device designed to provide support to patients with advanced heart failure by synchronizing with the heart's contractions.
Explore FineHeart's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.